NTLA · Intellia Therapeutics, Inc.
$11.91
+0.08 (+0.68%)
At close · Aug 14
Market Cap
$1.67B
Shares
140.13M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| — | — | — | — | — | 8-K , filed 2026-04-30 |
Key facts
CIK
1652130
CUSIP
45826J105
13F (30d)
334 filings
307 filers
Visit website
Investor relations